Sex-specific Cardiovascular Risk Factors and Treatment in Females with T2DM and CVD: Developments and Knowledge Gaps.
Erin S LeBlancNeon BrooksMelinda DaviesRanee ChatterjeePublished in: The Journal of clinical endocrinology and metabolism (2024)
To improve health of female patients with diabetes, sex-specific cardiovascular risk factors should be taken into account in screening and treatment decisions. Further, studies of cardiovascular and diabetes medications must ensure adequate representation by sex and report participant characteristics and outcomes by sex.